CLA induced milk fat depression reduced dry matter intake and improved energy balance in dairy goats

Animal dietary exposure in the risk assessment of feed derived from genetically modified plants

EFSA carries out the risk assessment of genetically modified plants for food and feed uses under Regulation (EU) No 503/2013. Exposure assessment - anticipated intake/extend of use shall be an essential element of the risk assessment of genetically modified feeds, as required by Regulation (EU) No 503/2013. Estimates of animal dietary exposure to newly expressed proteins should be determined to cover average consumption across all the different species, age, physiological and productive phases of farmed and companion animals, and identify and consider particular consumer groups with expected higher exposure. This statement is aimed at facilitating the reporting of the information that applicants need to provide on expected animal dietary exposure to newly expressed proteins and to increase harmonisation of the application dossiers to be assessed by the EFSA GMO Panel. Advice is provided on the selection of proper feed consumption and feed concentration data, and on the reporting of exposure's estimates. An overview of the different uncertainties that may be linked to the estimations is provided. This statement also explains how to access an Excel calculator which should be used in future applications as basis to provide a more consistent presentation of estimates of expected animal dietary exposure.

Recent Insights Into Processing Approaches and Potential Health Benefits of Goat Milk and Its Products: A Review

Goat milk is considered to be a potential source of various macro- and micro-nutrients. It contains a good proportion of protein, fat, carbohydrates, and other nutritional components which help in promoting nutritional and desirable health benefits. Goat milk is considered to be superior in terms of numerous health benefits, and lower risk of allergy, when compared to the milk of other species. Several processing techniques such as pasteurization, ultrafiltration, microfiltration, and ultrasound have been employed to enhance the quality and shelf life of goat milk and its products. The diverse range of goat milk-based products such as yogurt, cheese, fermented milk, goat milk powder, and others are available in the market and are prepared by the intervention of advanced processing technologies. Goats raised in pasture-based feeding systems are shown to have a better milk nutritional composition than its counterpart. Goat milk contains potential bioactive components, which aids in the maintenance of the proper metabolism and functioning of the human body. This review gives insight into the key nutritional ingredients and bioactive constituents present in goat milk and their potential role in the development of various functional foods using different processing technologies. Goat milk could be considered as a significant option for milk consumption in infants, as compared to other milk available.

Energy balance in lactating goats: Response to mixture of conjugated linoleic acid

The objective of this study was to determine the energy balance in early lactating local goats when supplemented with conjugated linoleic acid. Fifteen local goats from the north-east of Mexico were used. Three treatments were evaluated: (a) Control (Base diet); (b) CLA 50 g; and (c) CLA 90 g. The CLA was a mixture of micro-encapsulated FA, which supplied c9, t11 and t10, c12. Goats had an adaptation period of 2 weeks and 7 experimental weeks. The variables evaluated were body weight, DMI, milk yield, and fat, protein, and lactose yield, FA milk profile, and energy balance. The analysis of the data was analyzed as repeated measures using the PROC MIXED procedure and Tukey test (p < .05). In milk of goats from the treatment 90 g of the isomer t10, c12 CLA (p < .05) the milk fat content and milk fat yield with respect to the control treatment were reduced and the energy balance was improved. In goats treated with 11 g of t10, c12 CLA increased (p < .05) milk yield and milk lactose content. These results suggest that energy not used to synthesize dairy fat was used to increase milk yield and improve energy balance.

Composition, Mineral and Fatty Acid Profiles of Milk from Goats Fed with Different Proportions of Broccoli and Artichoke Plant By-Products

In the Mediterranean region, artichoke and broccoli are major crops with a high amount of by-products that can be used as alternative feedstuffs for ruminants, lowering feed costs and enhancing milk sustainability while reducing the environmental impact of dairy production. However, nutritional quality of milk needs to be assured under these production conditions and an optimal inclusion ratio of silages should be determined. This work aimed to evaluate the effect of three inclusion levels (25%, 40%, and 60%) of these silages (artichoke plant, AP, and broccoli by-product, BB) in goat diets on milk yield, composition, and mineral and fatty profiles. Treatments with 60% inclusion of AP and BB presented the lowest milk yield. No differences were found on the milk mineral profile. Inclusion of AP in the animals' diet improved the milk lipid profile from the point of view of human health (AI, TI) compared to BB due to a lower saturated fatty acid content (C12:0, C14:0, and C16:0) and a higher concentration of polyunsaturated fatty acids (PUFA), especially vaccenic acid (C18:1 trans11) and rumenic acid (CLA cis9, trans11), without any differences with the control treatment.

The Effect of CLA-Rich Isomerized Poppy Seed Oil on the Fat Level and Fatty Acid Profile of Cow and Sheep Milk

The aim of the study was to examine the effect of dietary supplementation of isomerized poppy seed oil (IPO) enriched with conjugated dienes of linoleic acid (CLA) on cow and sheep milk parameters (fat content, fatty acid profile, Δ9-desaturase index, and atherogenic index). The process of poppy seed oil alkaline isomerization caused the formation of CLA isomers with cis-9,trans-11, trans-10,cis-12, and cis-11,trans-13 configurations in the amounts of 31.2%, 27.6%, and 4.1% of total fatty acids (FAs), respectively. Animal experiments were conducted on 16 Polish Holstein Friesian cows (control (CTRL) and experimental (EXP), n = 8/group) and 20 East Friesian Sheep (CTRL and EXP, n = 10/group). For four weeks, animals from EXP groups received the addition of IPO in the amount of 1% of dry matter. Milk was collected three times: on days 7, 14, and 30. Diet supplementation with IPO decrease milk fat content (p < 0.01). Milk fat from EXP groups had higher levels of polyunsaturated fatty acids, including FAs with beneficial biological properties, that is, CLA and TVA (p < 0.01), and lower levels of saturated fatty acids, particularly short- (p < 0.01) and medium-chain FAs (p < 0.05). The addition of IPO led to a decrease in the atherogenic index.

Regulation of Stearoyl-Coenzyme A Desaturase 1 by trans-10, cis-12 Conjugated Linoleic Acid via SREBP1 in Primary Goat Mammary Epithelial Cells

trans-10, cis-12 Conjugated linoleic acid (t10c12-CLA) is a biohydrogenation intermediate in the rumen that inhibits mammary fatty acid de novo synthesis in lactating dairy goats. However, the underlying molecular pathways in milk-lipid metabolism affected by t10c12-CLA are not completely understood. The present study investigated the lipid-regulation mechanisms in goat mammary epithelial cells (GMECs) in response to t10c12-CLA. Gene-expression analysis indicated sterol-regulatory-element-binding transcription factor1 ( SREBF1) and its putative target gene stearoyl-CoA desaturase ( SCD1) were down-regulated (fold changes of 0.33 ± 0.04, P < 0.05, and 0.19 ± 0.01, P < 0.01, respectively). Concentrations of cellular palmitoleic acid (C16:1) and oleic acid (C18:1) were decreased (1.12 ± 0.05 vs 1.69 ± 0.11% and 15.70 ± 0.44 vs 24.97 ± 0.82%, respectively, P < 0.01), whereas those of linoleic acid (C18:2) were increased (5.00 ± 0.14 vs 3.81 ± 0.25%, P < 0.05); the desaturation indices of C16 and C18 were decreased in response to t10c12-CLA treatment (6.90 ± 0.05 vs 8.00 ± 0.30% and 61.41 ± 0.65 vs 67.73 ± 1.33%, respectively, P < 0.05). A luciferase-activity assay indicated that deletion of the sterol-response-element (SRE) site and the nuclear-factor (NF-Y) site in the SCD1-promoter region (-511/+65 bp) suppressed the regulatory effect of t10c12-CLA. Overexpression of SREBF1 partly counteracted the inhibitory effect of t10c12-CLA on de novo fatty acid synthesis. Overall, t10c12-CLA causes an inhibition of fatty acid synthesis and desaturation and regulates SCD1 expression by affecting the binding of SREBP1 protein to the SRE and NF-Y sites.

The comparison of the lactation and milk yield and composition of selected breeds of sheep and goats

The objective of this study was to characterize the milk yield (MY) and milk composition of relevant sheep and goat breeds raised around the world to be used with nutrition models for diet formulation and nutrient balancing. A 2-step approach was used. First, a database developed by the Food and Agriculture Organization was used to identify relevant breeds (i.e., frequently raised) by comparing the occurrence of transboundary breed names across countries. We selected transboundary breeds that occurred more than 3 times and other relevant breeds obtained from the specialized literature that had milk production information (e.g., MY, days in milk, and milk fat, protein, and lactose). The majority of sheep breeds were classified as nondairy (76%) because they lacked milk production information. Karakul and Merino accounted for up to 2.4% of sheep breeds raised around the world, whereas the other individual breeds accounted for less than 1%. In contrast, nondairy breeds of goats accounted for 46.3% and of the remaining 53.7%, Saanen, Boer, Anglo-Nubian, Toggenburg, and Alpine accounted for 6.5, 5, 4.4, 4, and 3%, respectively, of the transboundary breeds. Second, a database compiled from published studies for the selected sheep (n = 65) and goats (n = 78) breeds were analyzed using a random coefficients model (studies and treatments within studies as random effects). For sheep breeds, the average and SD were 1.1 ± 0.3 kg/d for MY, 6.9 ± 1% for milk fat, 5.4 ± 0.4% for milk protein, 5 ± 0.3% for milk lactose, 17.7 ± 1.4% for milk total solids, and 1,073 ± 91 kcal/kg of milk energy. Lacaune had the greatest MY compared to Comisana and Tsigai (1.65 versus 0.83 and 0.62 kg/d; respectively, P < 0.05), but milk components were not different among breeds. For goats breeds, the average and SD across breeds were 1.7 ± 0.6 kg/d for MY, 4.2 ± 0.9% for milk fat, 3.3 ± 0.4% for milk protein, 4.4 ± 0.4% for milk lactose, 12.7 ± 1.1% for milk total solids, and 750 ± 75 kcal/kg of milk energy. Alpine had similar MY to Saanen (2.66 versus 2.55 kg/d, respectively; P > 0.05), but greater (P < 0.05) than other breeds. The Boer breed had the greatest milk fat, protein, lactose, and total solids than several other breeds, leading to the greatest milk energy content (907 kcal/kg). Because there are many factors that can alter MY and milk composition, averages provided in this study serve as guidelines, and nutritionists must obtain observed values when using nutrition models.

trans-10,cis-12-Conjugated Linoleic Acid Affects Expression of Lipogenic Genes in Mammary Glands of Lactating Dairy Goats

The molecular mechanisms on milk fat depression (MFD) in response to trans-10,cis-12-conjugated linoleic acid (t10,c12-CLA) supplementation in ruminants were elucidated in this research with dairy goats. A total of 30 2-year-old Xinong Saanen dairy goats [40 ± 5 days in milk (DIM)] at peak lactation stage were assigned to a 3 × 3 Latin square design (14 day treatment period, followed with 14 day washout). Three CLA treatments included (a) control, fed the basal diet only without CLA supplementation; (b) orally supplemented with 8 g/day of lipid-encapsulated CLA (low dose, CLA-1); and (c) orally supplemented with 16 g/day of lipid-encapsulated CLA (high dose, CLA-2). Expression levels of fatty acid metabolism genes in the mammary tissues were analyzed by real-time quantitative polymerase chain reaction (RT-qPCR) in three goats on day 1 and the other three goats on day 14 in each group after the discontinuation of CLA treatment in the third experimental period. Dietary supplementation of CLA led to a significant decrease of milk fat compared to the control (p < 0.05). Milk fat concentrations in CLA-1 and CLA-2 groups were 2.74 and 2.42%, respectively, while the milk fat concentration in the control group was 2.99%. Decreases in short- and medium-chain fatty acids (<16 carbons) and increases in unsaturated fatty acids were observed in the CLA-2 group (p < 0.05). The desaturation indexes of C16 and C18 fatty acids were obviously increased (p < 0.01). RT-qPCR results revealed decreases of the mRNA expression levels of SREBF1, PPARG, LPL, CD36, FABP3, ACSL1, FASN, ACACA, DGAT2, TIP47, ADRP, and BTN1A1 genes in mammary glands (p < 0.05) and an increase of the SCD gene because of CLA supplementation (p < 0.05). In conclusion, t10,c12-CLA-induced MFD was possibly the result from the downregulation of genes involved in lipogenesis in goat mammary glands.